EU CTR 536/2014 Training

Part 1 – Key Principles of Procedural Aspects

This first part of the course takes you inside the procedural foundations of the EU Clinical Trials Regulation (EU CTR). Step by step, you’ll learn how trials are assessed and coordinated across Europe, and how to prepare robust submissions that meet regulatory expectations.

What you will gain in Part 1:

  • Understand the roles of Reporting Member States (RMS) and Concerned Member States (CMSs).

  • Learn how the assessment process under EU CTR is structured and what it means for your studies.

  • Understand the Clinical Trial Application (CTA) dossier – Part I and Part II.

  • Explore requirements for Investigational Medicinal Products (IMP) and Auxiliary Medicinal Products (AxMP).

  • Build confidence in submission planning and responding effectively to Health Authority Queries.

Why this matters:
By learning these key principles, you’ll build a strong base for working under EU CTR. This will help you handle submissions more smoothly, avoid delays, and manage your trials with greater confidence.

    • 40 minutes

      Course duration
      Need an Invoice? Please Read This First
      If you need an invoice for the training, please do not proceed with the online payment. Instead, send your company details and any other necessary information to finance@kontekst.com.
      We will get back to you as soon as possible.


      This course was prepared in collaboration with experienced specialists in CTR and CTIS.


      About the Experts
      Katarzyna Kopacz-Zakrzewska, MPharm
      Regulatory Affairs professional with 8 years of experience in global, innovative pharmaceutical companies. Pharmacist by training, with strong expertise in human medicinal products and broad regulatory knowledge across the EMEA region. Experienced in oncology, early development programs, including registration strategy development, clinical trial applications, EMA Scientific Advice as well as post-authorisation activities.

      Edyta Maciołek / CTR consulting
      Clinical trials professional with over 15 years of experience in the pharmaceutical and biotechnology industry. Independent consultant on regulatory strategies and registration of clinical trials in the European Union. Expert and promoter of Regulation (EU) 536/2014 and CTIS.

      Created with